May 21, 2026
Business Development Manager – CDMO – Therapeutics/Life Science at LGC Group (USA)
Company DescriptionAxolabs specialises in a new class of drugs whose active ingredients are chemically derived from DNA or RNA. They are called oligonucleotide or nucleic acid therapeutics. We use our…
Description
Company DescriptionAxolabs specialises in a new class of drugs whose active ingredients are chemically derived from DNA or RNA. They are called oligonucleotide or nucleic acid therapeutics. We use our…
Apply
Story date: May 21, 2026
Sources
- Business Development Manager – CDMO – Therapeutics/Life Science at LGC Group - Jobicy RSS | 2026-05-21